Rossi, Carlo Maria http://orcid.org/0000-0003-1314-361X
Lenti, Marco Vincenzo
Merli, Stefania
Lo Bello, Antonio
Mauro, Aurelio
Anderloni, Andrea
Ribaldone, Davide Giuseppe
Marabotto, Elisa
Vernero, Marta
Sheijani, Shirin Djahandideh
Maniero, Daria
Vanoli, Alessandro
Klersy, Catherine
Savarino, Edoardo Vincenzo
Di Sabatino, Antonio
Funding for this research was provided by:
Department of Molecular Medicine, University of Pavia (PRIN)
Università degli Studi di Pavia
Article History
Received: 7 November 2023
Accepted: 19 February 2024
First Online: 10 March 2024
Declarations
:
: Edoardo Vincenzo Savarino has served as speaker for Abbvie, Agave, AGPharma, Alfasigma, Aurora Pharma, CaDiGroup, Celltrion, Dr Falk, EG Stada Group, Fenix Pharma, Fresenius Kabi, Galapagos, Janssen, JB Pharmaceuticals, Innovamedica/Adacyte, Malesci, Mayoly Biohealth, Omega Pharma, Pfizer, Reckitt Benckiser, Sandoz, SILA, Sofar, Takeda, Tillots, Unifarco; has served as consultant for Abbvie, Agave, Alfasigma, Biogen, Bristol-Myers Squibb, Celltrion, Diadema Farmaceutici, Dr. Falk, Fenix Pharma, Fresenius Kabi, Janssen, JB Pharmaceuticals, Merck & Co, Nestlè, Reckitt Benckiser, Regeneron, Sanofi, SILA, Sofar, Synformulas GmbH, Takeda, Unifarco; he received research support from Pfizer, Reckitt Benckiser, SILA, Sofar, Unifarco, Zeta Farmaceutici. The other authors report no conflict of interests to disclose.
: The study was approved by the local ethics committee.
: Informed consent from all patients was obtained.
: The authors states that this research was conducted in accordance with the Helsinki Declaration as revised in 2008. This study did not involve animal.